Concepedia

Publication | Closed Access

The novel calicheamicin-conjugated CD22 antibody inotuzumab ozogamicin (CMC-544) effectively kills primary pediatric acute lymphoblastic leukemia cells

DOI

114

Citations

32

References

2011

Year

Jeltje F. de Vries, C. Michel Zwaan, Maaike de Bie, Jane S.A. Voerman, Monique L. den Boer, Jacques J. M. van Dongen, Vincent H. J. van der Velden
Leukemia

References

YearCitations

Page 1